Herbal remedies - A potential source of drug interactions;Pflanzliche arzneimittel: Eine mögliche quelle von wechseiwirkungen

Internist

Volumn 44, Issue 6, 2003, Pages 748-752

  Morike K ^a   Gleiter, C H ^b  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b NONE

Author keywords

Cytochrome P450; Echinacea; Ginkgo; Herbal remedies; Interactions; St John'wort

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIDEPRESSANT AGENT; CYCLOSPORIN; CYTOCHROME P450; DIGOXIN; ECHINACEA EXTRACT; ERGOTAMINE; FEXOFENADINE; GARLIC EXTRACT; GINKGO BILOBA EXTRACT; GINSENG EXTRACT; HERBACEOUS AGENT; HYPERICUM PERFORATUM EXTRACT; IRINOTECAN; MIDAZOLAM; ORAL CONTRACEPTIVE AGENT; PARACETAMOL; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR; TACROLIMUS; THEOPHYLLINE DERIVATIVE;

DRUG RESEARCH; DRUG SAFETY; GRAFT REJECTION; HERBAL MEDICINE; HUMAN; LIVER TOXICITY; PRESCRIPTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SIDE EFFECT; TREATMENT FAILURE;

EID: 18244420926     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-003-0969-6     Document Type: Review

References (43)

1. Abebe W (2002) Herbal medication: potential for adverse interactions with analgesic drugs. J Clin Pharmacy Ther 27:391-401
2. Anon (2000) Risk of drug interactions with St John's wort. JAMA 283;1679
3. Barone GW, Gurley BJ, Ketel BL, Abul-Ezz SR (2001) Herbal supplements: A potential for drug interactions in transplant patients. Transplantation 71:239-241
4. Burstein AH, Horton RL, Dunn T, Alfaro RM, Piscitelli SC, Theodore W (2000) Lack of effect of St John's Wort on carbamazepine pharmacokinetics in healthy volunteers. Clin Pharmacol Ther 68:605-612
5. De Smet PAGM (2002) Herbal remedies. N Engl J Med 347:2046-2056
6. Dresser GK, Schwarz UI, Wilkinson GR, Kim RB (2003) Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects. Clin Pharmacol Ther 73:41-50
7. Dürr D, Stieger B, Kullak-Ublick GA, Rentsch KM, Steinert HC, Meier PJ, Fattinger K (2000) St John's Wort induces intestinal P-glycoprotein/MDR1 and intestinal and hepatic CYP3A4. Clin Pharmacol Ther 68:598-604
8. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL (1993) Unconventional medicine in the United States - prevalence, costs, and patterns of use. N Engl J Med 328:246-252
9. Ernst E (2000) Herb-drug interactions: potentially important but woefully under-researched. Eur J Clin Pharmacol 56:S23-S24
10. Ernst E (2003) Serious adverse effects of unconventional therapies for children and adolescents: a systematic review of recent evidence. Eur J Pediatr 162:72-80
11. Fugh-Berman A (1999) Herbal medicinals: Selected clinical considerations, focusing on known or potential drug-herb interactions. Arch Intern Med 159:1957-1958
12. Fugh-Berman A (2000) Herb-drug interactions. Lancet 355:134-138
13. Gallicano K, Foster B,Choudhri S (2003) Effect of short-term administration of garlic supplements on single-dose ritonavir pharmacokinetics in healthy volunteers. Br J Clin Pharmacol 55:199-202
14. Gurley BJ, Gardner SF, Hubbard MA et al. (2002) Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther 72:276-287
15. Henderson L, Yue QY, Bergquist C, Gerden B, Arlett P (2002) St John's wort (Hypericum perforatum): drug interactions and clinical outcomes. Br J Clin Pharmacol 54:349-356
16. Hennessy M, Kelleher D, Spiers JP et al. (2002) St John's Wort increases expression of P-glycoprotein: Implications for drug interactions. Br J Clin Pharmacol S3:75-82
17. Hindmarch M, Oakeshott P (2002) Interactions of the oral contraceptive pill with antibiotics and St John's wort: knowledge of female college students. Fam Pract 19:708
18. Ioannides C (2002) Pharmacokinetic interactions between herbal remedies and medicinal drugs. Xenobiotica 32:451-478
19. Johne A, Brockmöller J, Bauer S, Maurer A, Langheinrich M, Roots I (1999) Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericura perforatum). Clin Pharmacol Ther 66:338-345
20. Johne A, Schmider J, Brockmölle TJ et al. (2002) Decreased plasma levels of amitriptyline and its metabolites on comedication with an extract from St. John's wort (Hypericum perforatum).J Clin Psychopharmacol 22:46-54
21. Karliova M, Treichel U, Malagò M, Frilling A, Gerken G, Broelsch CE (2000) Interaction of Hypericum perforatum (St.John's wort) with cyclosporin A metabolism in a patient after liver transplantation. J Hepatol 33:853-855
22. de Maat MMR, Haetelmans MRW, Mathôt RAA, van Gorp ECM, Meenhorst PL, Mulder JW, Beijnen JH (2001) Drug interaction between St John's wort and nevirapine. AIDS 15:420-421
23. Mai I, Störmer E, Bauer S, Krüger H, Budde K, Roots I (2003) Impact of St John's wort treatment on the pharmacokinetics of tacrolimus and mycophenolic acid in renal transplant patients. Nephrol Dial Transplant 18:819-822
24. Mathijsen RHJ, Verweij J, de Bruijn P, Loos WJ, Sparreboom A (2002) Effects of St. John's wort on irinotecan metabolism. J Natl Cancer Inst 94:1247-1249
25. Maurer A, Johne A, Bauer Set al. (1999) Interaction of St. John's wort extract with phenprocoumon (abstract). Eur J Clin Pharmacol SS:A22
26. Miller LG (1998) Herbal medicines. Selected clinical considerations focusing on known or potential drug-herb interactions. Arch Intern Med 158:2200-2211
27. Moore LB, Goodwin B, Jones SA et al. (2000) St John's wort induces hepatic drug metabolism through activation of the pregnane X receptor. Proc Natl Acad Sci U S A 97:7500-7502
28. Nebel A, Schneider BJ, Baker RK, Kroll DJ (1999) Potential metabolic interaction between St. John's Wort and theophylline. Ann Pharmacother 33:502
29. Perloff M D, von Moltke LL, Störmer E, Shader RI, Greenblatt DJ (2001) Saint John's wort: An in vitro analysis of P-glycoprotein induction due to extended exposure. Br J Pharmacol 134:1601-1608
30. Piscitelli SC, Burstein AH, Chaitt D, Alfaro RM, Falloon J (2000) Indinavir concentrations and St John's wort. Lancet 355,547-548
31. Piscitelll SC, Burstein AH, Welden N, Gallicano KD, Falloon J (2002) The effect of garlic supplements on the pharmacokinetics of saquinavir. Clin Infect Dis 34:234-238
32. Rowin J, Lewis SL (1996) Spontaneous bilateral subdural hematomas associated with chronic Ginkgo biloba ingestion. Neurology 46:1775-1776
33. Ruschitzka F, Meier PJ, Turina M, Lüscher TF, Noll G (2000) Acute heart transplant rejection due to Saint John's wort. Lancet 355:548-549
34. Schwarz UI, Büschel B, Kirch W (2003) Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception. Br J Clin Pharmacol 55:112-113
35. Skinner CM, Rangasami J (2002) Preoperative use of herbal medicines: a patient survey. Br J Anaesth 89:792-795
36. Sugimoto K, Ohmori M, Tsuruoka S et al. (2001) Different effects of St John's Wort on the pharmacokinetics of simvastatin and pravastatin. Clin Pharmacol Ther 70:518-524
37. Tsen LC, Segal S, Pothier M, Bader AM (2000) Alternative medicine use in presurgical patients. Anesthesiology 93:148-151
38. Vaes LPJ, Chyka PA (2000) Interactions of warfarin with garlic, ginger, ginkgo, or ginseng: Nature of evidence. Ann Pharmacother 34,1478-1482
39. Valli G, Giardina EGV (2002) Benefits, adverse effects and drug interactions of herbal therapies with cardiovascular effects. J Am Coll Cardiol 39:1083-1095
40. Wang Z, Hamman MA, Huang S-M, Lesko U, Hall SD (2002) Effect of St John's wort on the pharmacokinetics of fexofenadine. Clin Pharmacol Ther 71:414-420
41. Yue Q-Y, Bergquist C, Gerdén B (2000) Safety of St John's wort (Hypericum perforatum). Lancet 355:576-577
42. Zeeck A, Bach G, Terlau H (2001) Das medizinische Potential von Naturstoffen. Internist 42:1422-1427
43. Zhou S, Gao Y, Jiang W, Huang M, Xu A, Paxton JW (2003) Interactions of herbs with cytochrome P450. Drug Metab Rev 35:35-98